No Evidence That Hormonal IUDs Increase HSV Outbreak Frequency
There is no established evidence that levonorgestrel-releasing intrauterine devices (hormonal IUDs) cause increased frequency or severity of herpes simplex virus outbreaks in women with recurrent HSV infection.
Evidence Review
The available medical literature does not demonstrate a causal relationship between hormonal IUD use and HSV outbreak patterns:
Direct Evidence on Hormonal Contraception and HSV
The most relevant prospective study examined hormonal contraceptive initiation in 200 HIV-positive, HSV-2-seropositive women 1. Cervical HSV detection actually decreased after starting hormonal contraception (from 16.0% to 12.5%, p=0.4), with a median reduction of 313 viral copies per swab among women who shed virus. This study found no significant differences between combination oral contraceptives and progesterone-only methods.
Theoretical Considerations from IUD Literature
While some research has identified viral DNA in endometrial samples from IUD users, these findings do not establish causation for increased outbreaks:
- One older Chinese study 2 found higher rates of viral isolation (including HSV-II) in women with IUD-related bleeding compared to controls, but this was similar to rates in women with bleeding without IUDs, suggesting bleeding itself—not the IUD—was the relevant factor
- A case report 3 described asymptomatic herpes cervicitis in an IUD user, but this represents subclinical viral shedding rather than symptomatic outbreaks
- Research on immune changes with hormonal IUDs 4 showed both inflammatory and immunosuppressive alterations in the cervix and endometrium, but the clinical significance for HSV reactivation remains unknown
What the Guidelines Say
None of the major STI treatment guidelines 5, 6, 7, 6, 8 identify hormonal IUD use as a risk factor for HSV recurrence or list it as a consideration when counseling patients about genital herpes management. The comprehensive 2022 CDC guidelines 8 and 2024 European guidelines 9 make no mention of contraceptive method affecting outbreak frequency.
The FDA labeling for Kyleena (levonorgestrel IUD) 10 does not list HSV reactivation or increased outbreak frequency as a known adverse effect or warning.
Clinical Recommendation
You can reassure patients with recurrent HSV that choosing a hormonal IUD for contraception should not worsen their herpes outbreaks. If a patient reports increased outbreak frequency after IUD insertion, consider alternative explanations:
- Natural variation in HSV recurrence patterns (which typically decrease over time)
- Concurrent life stressors, illness, or immunosuppression
- New sexual partner exposure
- Coincidental timing unrelated to the IUD
For women with frequent recurrences (≥6 per year), daily suppressive antiviral therapy with acyclovir, valacyclovir, or famciclovir remains the evidence-based approach regardless of contraceptive method 6, 8.
Important Caveats
The absence of evidence for harm does not mean the question has been thoroughly studied. Most research on hormonal contraception and HSV has focused on oral contraceptives and injectables rather than IUDs specifically. However, given that:
- Hormonal IUDs deliver primarily local rather than systemic progestin effects
- The one prospective study on hormonal contraception showed no increase in HSV shedding 1
- No clinical guidelines or drug labels identify this as a concern
The weight of available evidence supports that hormonal IUDs do not increase HSV outbreak frequency and can be used safely in women with recurrent genital herpes.